Dialogue-Based Webinar for Coronavirus

Phase-Based Progress Estimates
Dartmouth College, Lebanon, NHCoronavirus+7 MoreDialogue-Based Webinar - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines by comparing two different interventions to usual online information.

Eligible Conditions
  • Coronavirus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 18 Secondary · Reporting Duration: Baseline (Time 0); 3 weeks post-randomization (Time 1); 3 months post-randomization (Time 2); 6 months post-randomization (Time 3)

Week 3
COVID-19 vaccine confidence
COVID-19 vaccine intent (booster)
COVID-19 vaccine intent (future vaccine recommendations)
COVID-19 vaccine intent (initial series)
COVID-19 vaccine uptake (any dose)
COVID-19 vaccine uptake (booster completion)
COVID-19 vaccine uptake (initial series completion)
Feeling informed about the COVID-19 vaccines
Identification of COVID-19 vaccine information and misinformation
Knowledge about the COVID-19 vaccines
Likelihood of recommending COVID-19 booster vaccination to coworker
Likelihood of recommending COVID-19 vaccination
Likelihood of recommending COVID-19 vaccination (coworker)
Likelihood of recommending COVID-19 vaccination (friend or family member)
Trust in COVID-19 vaccine information from different sources
Month 3
Dialogue-Based Webinar acceptability
Enhanced Usual Practice acceptability
Social Media Website acceptability
Month 6
As-treated analyses of primary
Change from baseline in
Change from baseline in COVID-19 vaccine confidence
Change in
Change in COVID-19 vaccine confidence
Time of individual participants' exposure to intervention
Dialogue-Based Webinar exposure
Social Media Website exposure

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Enhanced Usual Practice
1 of 3
Dialogue-Based Webinar
1 of 3
Social Media Website
1 of 3

Active Control

Experimental Treatment

1800 Total Participants · 3 Treatment Groups

Primary Treatment: Dialogue-Based Webinar · No Placebo Group · N/A

Dialogue-Based Webinar
Experimental Group · 1 Intervention: Dialogue-Based Webinar · Intervention Types: Behavioral
Social Media Website
Experimental Group · 1 Intervention: Social Media Website · Intervention Types: Behavioral
Enhanced Usual Practice
ActiveComparator Group · 1 Intervention: Enhanced Usual Practice · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline (time 0); 3 weeks post-randomization (time 1); 3 months post-randomization (time 2); 6 months post-randomization (time 3)

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
491 Previous Clinical Trials
2,530,511 Total Patients Enrolled
National Association of Health Care AssistantsUNKNOWN
Institute for Healthcare ImprovementOTHER
6 Previous Clinical Trials
11,914 Total Patients Enrolled
East Carolina UniversityOTHER
96 Previous Clinical Trials
33,473 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
497 Previous Clinical Trials
29,837,346 Total Patients Enrolled
Glyn ElwynPrincipal InvestigatorDartmouth College
2 Previous Clinical Trials
499 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have concerns about the safety or effectiveness of COVID-19 vaccines or have not yet received a booster shot.

Frequently Asked Questions

Are there any available spots to join this investigation?

"Affirmative. Clinicaltrials.gov confirms that this clinical experiment, which was uploaded on February 21st 2022, is actively searching for participants. The researchers need to enroll 1800 patients from a single location." - Anonymous Online Contributor

Unverified Answer

What is the recruitment capacity of this research project?

"Affirmative. Clinicaltrials.gov provides information which attests to the active recruitment for this medical trial, first posted on February 21st 2022 and most recently updated October 13th 2022. 1800 patients are being sought from one designated facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.